KARAMJEET SINGH SANDHU

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology DUARTE, CA NPI 1144457979

General Payments — all program years on this page

$1,744.51

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $828.53 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $828.5315

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $146.526
2020 $102.254
2021 $113.365
2022 $403.706
2023 $150.155
2024 $828.5315

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087339757 Novartis Pharmaceuticals Corporation $94.06 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093941646 Alexion Pharmaceuticals, Inc. $51.25 12/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126828438 Genmab U.S., Inc. $27.58 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133044189 Genentech USA, Inc. $28.17 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137507867 Ferring Pharmaceuticals Inc. $73.44 10/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139765736 GENZYME CORPORATION $18.40 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144966571 Takeda Pharmaceuticals U.S.A., Inc. $21.92 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145203989 Rigel Pharmaceuticals, Inc. $0.97 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145203991 Rigel Pharmaceuticals, Inc. $16.16 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150201298 JAZZ PHARMACEUTICALS INC. $123.12 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150201300 JAZZ PHARMACEUTICALS INC. $107.11 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150201302 JAZZ PHARMACEUTICALS INC. $2.69 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150201304 JAZZ PHARMACEUTICALS INC. $30.36 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150201306 JAZZ PHARMACEUTICALS INC. $89.87 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150201308 JAZZ PHARMACEUTICALS INC. $143.43 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.